Age is (by far) the biggest risk factor for CVD.
This review article discusses why, and what can be done to slow the aging of the cardiovascular system.
It is probably the best review article written on the subject to date.
———-
Impact of Geroscience [the science of aging] on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement
“This hypothetical common root to chronic diseases [aging] explains why patients with CVD are often affected by multimorbidity and frailty and why older age negatively affects CVD prognosis and treatment response.”
“Here, we describe the main resilience mechanisms of mammalian aging, with a focus on how they can affect CVD pathophysiology. We next present novel gerotherapeutic approaches, some of which are already used in management of CVD, and explore their potential to transform care and management of CVD. The geroscience paradigm is gaining traction broadly in medical specialties, with potential to mitigate premature aging, reduce health care disparities, and improve population healthspan.”
Paper · JACC · 2023Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Diseasesciencedirect.com



